Literature DB >> 20339103

Early response predicts myeloma outcome.

Antonio Palumbo1.   

Abstract

Entities:  

Year:  2010        PMID： 20339103     DOI： 10.1182/blood-2010-02-268730

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  1 in total

1.  Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation.

Authors:  Ho Sup Lee; Yang Soo Kim; Kihyun Kim; Jin Seok Kim; Hyo Jung Kim; Chang-Ki Min; Cheolwon Suh; Hyeon-Seok Eom; Sung-Soo Yoon; Jae Hoon Lee; Min Kyong Kim; Sung-Hyun Kim; Sung Hwa Bae; Yeung-Chul Mun; Deog Yeon Jo; Joo-Seop Chung
Journal:  J Korean Med Sci       Date:  2013-01-08       Impact factor: 2.153
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.